Mad Money 08/06/26 | Audio Only
Спикеры
Jim Cramer
— Ведущий, Mad Money
Jim Cramer presents five investment themes from Q2 2026 earnings: consumer strength, semiconductor equipment, cybersecurity, M&A banking, and healthcare innovation. He interviews the CEOs of BD, Constellation Brands, and Akamai, reinforcing bullish calls on each. In the lightning round, he offers quick views on several stocks, mostly avoid or buy, and closes with a deep dive praising Ralph Lauren's retail excellence.
- Consumer spending is robust per bank data and travel demand; plays include Capital One, American Express, and Williams-Sonoma.
- Memory shortage in data centers drives a bullish call on semiconductor equipment makers Lam Research, KLA Corp, and Applied Materials.
- Cybersecurity stocks CrowdStrike and Palo Alto Networks are essential as AI-powered threats increase.
- A coming M&A wave under the Trump administration favors Goldman Sachs and Morgan Stanley as advisory powerhouses.
- Healthcare stocks Eli Lilly, Johnson & Johnson, Amgen, and Moderna offer non-tech innovation plays amid tech rotation.
- BD (Becton Dickinson) is highlighted as a cheap medtech with AI-driven growth after a strong quarter and split.
- Constellation Brands is cheap with strong beer brands, while Akamai is seen as a new AI edge computing play.
- Avoid calls on Bristol-Myers, Axon, Honeywell, Thompson Reuters, and Cipher Mining; bullish on Lockheed Martin.
Идеи
Merger creates credit card heavyweight
Consumer spending is surprisingly robust, as shown by Bank of America and Wells Fargo data and travel demand. Capital One, after merging with Discover, becomes a heavy hitter in credit cards, and the stock is down 9% for the year, making it a good way to play the strong consumer.
Wealthy clients drive strong spending
American Express has a rich clientele providing buoyancy. The stock (referred to as America's best) is down 7% for the year, presenting a buying opportunity alongside the strong consumer spending trend.
Strong consumer lifts high-end retail
Williams-Sonoma is a high-end retailer that benefits from the strong consumer, as evidenced by robust spending trends.
Memory shortage profits machine makers
A shortage of every kind of memory in data centers makes the companies that build the machines that make memory the most consistent and valuable. Lam Research, KLA Corp, and Applied Materials are the semiconductor capital equipment leaders, America's edge in chip manufacturing, with no worries about demand.
AI hackers make cyber stocks essential
Cybersecurity is not being commoditized. AI-powered hackers make CrowdStrike and Palo Alto Networks more essential than ever. These are some of the best stocks in the entire market, and despite taking partial profits after 100% gains, the thesis remains strong.
M&A boom under Trump enriches banks
Pent-up demand for mergers and acquisitions under the Trump administration's lax antitrust enforcement is creating a gold mine for M&A advisory. Goldman Sachs and Morgan Stanley, with their terrific M&A departments, will see huge earnings per share from this deal wave.
Healthcare innovation catches tech rotation
After tech's massive run, portfolio managers are seeking innovation in other sectors. Healthcare stocks like Eli Lilly, Johnson & Johnson, Amgen, and Moderna are non-tech tech stocks with strong quarters and pipelines, representing a rotation opportunity.
Limited upside, better picks exist
Bristol-Myers Squibb has limited upside after the AstraZeneca merger speculation. While not expensive with a 3.9% yield, there are better alternatives like Johnson & Johnson, suggesting it is time to trim.
Too big a run to buy
Axon Enterprise has had an amazing run for many years and is down only 8% after earnings, but the stock has simply run too far and Cramer does not want to touch it.
Poor communication, disappointing quarter
Honeywell had a suboptimal quarter with poor management communication, a rookie mistake. The travel trust sold the stock at the open; it is a great company but not ready for prime time.
Cheap medtech with AI-driven growth
BD (Becton Dickinson) is cheap at 14x forward earnings after a strong quarter. The post-split portfolio is number one in 90% of markets, with secular growth in connected care, AI, robotics, and GLP-1 delivery devices, making it a durable consistency play.
Beer brands strong, stock cheap
Constellation Brands stock is cut in half and sells for less than 11x earnings with a 3.1% yield. Core beer brands Modelo, Corona, and Pacifico are still growing, distribution gaps are closing, and new management signals a turnaround as temporary headwinds abate.
Edge computing for AI robotics boom
Akamai Technologies is transforming from content delivery to a unique AI edge computing and cybersecurity play. A $600M 4-year cloud infrastructure win in robotics, partnership with Nvidia, and accelerating overall growth make it a brand-new AI opportunity.
Defense giant with fantastic CEO
Lockheed Martin is sensational, with a fantastic CEO. It is a solid defense stock that will do just fine over the long term.
Value trap with too much competition
Thompson Reuters is always cheap but acts like a value trap due to too much competition and not enough intellectual property, making it unattractive.
Debt and earnings drag from pivot
Cipher Mining (Cipher Digital) is pivoting from bitcoin mining to AI data centers, but carries big capex debt load and short-term earnings drag, making it a stock to steer clear of.
Masterful branding drives retail growth
Ralph Lauren's CEO Patrice Louvet delivers a masterclass in retail execution. The brand is elevated through cinematic storytelling and key city strategies, driving 9% North America same-store sales, 23% Asia growth, and expanding margins, making it a must-own retail stock.
Далее
This CNBC video, published August 06, 2026, features Jim Cramer discussing COF, AXP, WSM, AMAT, LRCX, KLAC, CRWD, PANW, GS, MS, AMGN, MRNA, LLY, JNJ, BMY, AXON, HON, BDX, STZ, AKAM, LMT, TRI, CIFR, RL. 17 trade ideas extracted by AI with direction and confidence scoring.
Speakers: Jim Cramer · Tickers: COF, AXP, WSM, AMAT, LRCX, KLAC, CRWD, PANW, GS, MS, AMGN, MRNA, LLY, JNJ, BMY, AXON, HON, BDX, STZ, AKAM, LMT, TRI, CIFR, RL